Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03774485 · ClinicalTrials.gov registry record
Myoelectric GutPrint-Crohn's Disease
A clinical trial, sponsored by Stanford University.
- Completed
- Registry status
- 136
- Enrollment target
NCT03774485: Completed study, sponsored by Stanford University.
NCT03774485 is a clinical trial that has completed, run by Stanford University. The registered enrollment target is 136 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03774485 has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- 136 participants
- Enrollment target
Study Summary
A feasibility study for assessing and recording myoelectric activity in patients for early detection of flare in patients with Crohn's disease and differentiating the myoelectric signals from Crohn's disease patients in remission state and healthy controls.
Primary Outcome
Myoelectric activity pattern in Crohn's disease patients versus healthy controls
Interventions
- DEVICE G-Tech Gutcheck Myoelectric recording device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 136 participants |
| Start Date | 2019-01-01 |
| Est. Completion | 2023-06-15 |
What the finished NCT03774485 record still lists
NCT03774485 is an observational study that tracks outcomes without assigning an intervention. The registered 136 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which G-Tech Gutcheck Myoelectric recording device is the first listed.
NCT03774485 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03774485 about?
NCT03774485 is a clinical study titled "Myoelectric GutPrint-Crohn's Disease". A feasibility study for assessing and recording myoelectric activity in patients for early detection of flare in patients with Crohn's disease and differentiating the myoelectric signals from Crohn's disease patients in remission state and healthy controls.
What is the current status of trial NCT03774485?
This trial is currently completed. The enrollment target is 136 participants. The study started on 2019-01-01. Estimated completion is 2023-06-15.
What interventions are being tested in trial NCT03774485?
The interventions under investigation include: G-Tech Gutcheck Myoelectric recording device (DEVICE).
Who is sponsoring clinical trial NCT03774485?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01555892 · 136 participants · Phase 1
Cytotoxic T-Lymphocytes for EBV-positive Lymphoma, GRALE
- NCT03216525 · 136 participants · Phase 3
Alvimopan Versus Placebo in Patients Undergoing Radical Cystectomy on an Enhanced Recovery Protocol
- NCT04476901 · 136 participants · Phase 2
Administration of Allogeneic-MSC in Patients With Non-Ischemic Dilated Cardiomyopathy
- NCT04603898 · 136 participants · NA
Oxalate Formation From Ascorbic Acid
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI